Phenotypic Evolution from Nonfluent PPA to PSP
Objective: Progressive Supranuclear Palsy (PSP) and Nonfluent Primary Progressive Aphasia (nfvPPA) are clinicopathological entities within the 4-repeat tauopathy (4R tauopathy) spectrum. Increasing evidence suggests that…Evaluating YouTube as a source of health information on Parkinson’s disease
Objective: This study aimed to evaluate the quality, reliability, and engagement characteristics of YouTube videos on Parkinson's disease using standardized assessment tools. Background: Parkinson’s disease…[18F]-FDG-PET metabolic phenotyping in idiopathic normal pressure hydrocephalus: visual and voxel-wise evidence across neurodegenerative phenotypes
Objective: To characterise FDG-PET metabolic phenotypes in idiopathic normal pressure hydrocephalus (iNPH) using integrated visual and voxel-wise analyses. Background: iNPH is a potentially treatable cause…Biochemical and Nutritional Changes During Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: Findings from an Observational Cohort
Objective: To evaluate the clinical effectiveness of CSAI and associated changes in vitamin B status, homocysteine (Hcy) levels, and nutritional outcomes in patients with advanced…Holistic Sensor-Based Profiling of Parkinson’s Disease via Mixed Reality: Implementation and Multimodal Feasibility
Objective: To validate a novel multimodal mixed-reality (MR) platform utilizing HoloLens 2 for the automated assessment of Parkinson’s disease (PD) symptoms and to determine the…Risk of Ischemic Cerebrovascular Events in Patients with Deep Brain Stimulation for Parkinson’s Disease: A Cohort Study
Objective: To longitudinally assess the risk of ischemic cerebrovascular events in patients undergoing DBS Background: Longitudinal data on the potential impact of DBS on long-term…Smell as a Diagnostic Signature: Systematic Review and Meta-Analysis of UPSIT Accuracy in Distinguishing Parkinson’s Disease from Essential Tremor
Objective: To evaluate the diagnostic performance of the University of Pennsylvania Smell Identification Test (UPSIT) in differentiating Parkinson’s disease (PD) from essential tremor (ET) using…Prevalence and associated factors of sarcopenia among Thai patients with ambulatory Parkinson’s disease
Objective: Objectives: To determine the prevalence of Asian Working Group for Sarcopenia (AWGS) 2019-defined sarcopenia phenotypes, identify associated factors, and evaluate screening performance in Thai PD patients. Background: Sarcopenia is…Progression and disability in Parkinson’s disease: what else can be done?
Objective: to identify key modifiable factors in the treatment of patients with Parkinson's disease (PD) that can slow clinical progression and disability.ity. Background: PD is…Spatiotemporal Biomarkers of Early Postural Instability in Parkinson’s Disease: Implications for Early Intervention
Objective: To characterize spatiotemporal biomarkers derived from a quantitatively assessed pull test in patients with early Parkinson’s disease (PD). Background: The pull test is a…
- « Previous Page
- 1
- …
- 114
- 115
- 116
- 117
- 118
- …
- 1942
- Next Page »